Upon reviewing a sample of Medicare Part B payments for specimen validity testing billed in combination with urine drug testing, the Office of Inspector General found that Medicare improperly paid physician offices and clinical laboratories $66.3 million for these services.
|
|
Revenue Cycle Advisor Subscriber Content | |
Daily Q&A | Need expert advice? Email your questions for consideration in the Revenue Cycle Daily Advisor. Note: We do not guarantee that all questions will be answered. | |
Product Spotlight Don’t be frustrated by the difficulty of coding peripheral vascular procedures —ensure your coders are on the same page by attending this three-hour virtual workshop from expert speaker Stacie L. Buck, RHIA, CCS-P, RCC, CIRCC. She will guide participants through the components of successful coding and review case studies that highlight frequently challenging clinical scenarios. | |
| What's New | Learn how a rural hospital’s staff collaborated to address the difficult task of preparing for Meaningful Use requirements. | |
What is Revenue Cycle Advisor? | Revenue Cycle Advisor combines all of HCPro's revenue cycle and Medicare regulatory and reimbursement resources in one place—whether you’re looking for information on billing, coding, CDI, case management, finance, or HIPAA. Don’t just read the news—read our in-depth expert analysis on the latest rules and regulations. Click the links below to: Learn more about becoming a member View a short demo of the site | |
Career Center | Post your open positions or find your next career move with the HCPro Career Center. | |
|
|
|